ArticleFrontiers in public health2022
Molecular epidemiology and antimicrobial resistance of
Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 14 citations in OpenAlex.
- Multidrug resistance and genomic characteristics of nontypeableMicrobiology spectrum · 2026Article
- Surveillance of epidemiological characteristics and temporal trends in antimicrobial resistance of Haemophilus influenzae in pediatric lower respiratory tract infections (2021-2024).Scientific reports · 2026Article
- Genetic organization and mobile-element basis of β-lactam resistance in a polyclonal respiratoryFrontiers in microbiology · 2026Article
- Antimicrobial resistance characteristics and associated molecular mechanisms of clinically isolatedFrontiers in cellular and infection microbiology · 2026Article
- Haemophilus influenzae global epidemiology and antimicrobial susceptibility patterns including ampicillin and amoxicillin-clavulanate resistance based on β-lactamase production, 2013-2022.BMC infectious diseases · 2025Article
- Characteristics of 241 invasive and non-invasive Haemophilus influenzae isolated from patients under 14 years old, Hebei Province, China.BMC infectious diseases · 2025Observational
- Molecular and Drug Resistance Characteristics ofMicroorganisms · 2025Article
- Epidemiology of invasive Haemophilus influenzae infections in Belgium: 2018-2022.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025Article
- Bacterial Epidemiology and Antimicrobial Resistance in Children in Shandong Province, China, 2017-2022: A Multicentre Retrospective Study.Infection and drug resistance · 2025Article
- Exploiting haem-iron dependence of nontypeableFrontiers in cellular and infection microbiology · 2025Review
- Development and implementation of a core genome multilocus sequence typing scheme forMicrobial genomics · 2024Article
- Analysis of data from two influenza surveillance hospitals in Zhejiang province, China, for the period 2018-2022.PloS one · 2024Article
- Characterization of Serotypes and Molecular Drug Resistance Patterns ofPolish journal of microbiology · 2023Article
- Molecular Epidemiology and Antibiotic Resistance Analysis of Non-TypeableAntibiotics (Basel, Switzerland) · 2023Article
- Antibacterial Activity ofInfection and drug resistance · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The widespread use of antimicrobials and Objective: To determine the serotype distribution, antimicrobial resistance and Multilocus Sequence Typing (MLST) of Methods: A total of 196 clinical isolates from hospitalized patients were collected. Serotypes were determined according to the specific capsule gene, Results: All isolates studied were non-typeable Conclusion:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.